https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-15 / World J Gastrointest Oncol 2015 Nov;7(11):338-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-15 / World J Gastrointest Oncol 2015 Nov;7(11):338-462015-11-15 00:00:002015-11-15 00:00:00Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-20 / J Gastrointest Surg 2013 Sep;17(9):1609-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-20 / J Gastrointest Surg 2013 Sep;17(9):1609-172013-07-20 00:00:002024-08-26 09:28:16Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-02-01 / Hum Vaccin Immunother 2013 May;9(5):1069-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-02-01 / Hum Vaccin Immunother 2013 May;9(5):1069-722013-02-01 00:00:002024-08-26 09:28:16Current status of immunotherapy for the treatment of biliary tract cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-01 / J Hepatobiliary Pancreat Sci 2012 Mar;19(2):171-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-01 / J Hepatobiliary Pancreat Sci 2012 Mar;19(2):171-82012-03-01 00:00:002012-03-01 00:00:00Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-902009-11-01 00:00:002009-11-01 00:00:00[The case of tumor escape mechanism by changing their tumor-associated antigens]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-62009-11-01 00:00:002009-11-01 00:00:00[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Cancer Ther 2008;6(B):955-964
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Cancer Ther 2008;6(B):955-9642008-01-01 00:00:002019-02-15 08:52:42A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-242006-09-01 00:00:002024-08-26 09:28:19Successful immunological treatment of gallbladder cancer in India–case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Surg. Today 2006;36(6):559-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Surg. Today 2006;36(6):559-622006-01-01 00:00:002019-02-15 08:36:22Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-01 / Oncol. Rep. 2005 Aug;14(2):353-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-01 / Oncol. Rep. 2005 Aug;14(2):353-62005-08-01 00:00:002019-02-15 08:36:23Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma
